4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Analyst Earnings Estimates
NASDAQ:FDMT - Nasdaq - US35104E1001 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.13M -82.65% | 20.723M 562.08% | 37K -99.82% | 4.324M 11,586.49% | 3.202M -25.95% | 4.005M 25.08% | 19.941M 397.90% | 108.65M 444.86% | 264.34M 143.29% | 509.84M 92.87% | 802.26M 57.36% | |
| EBITDA YoY % growth | -107.63M -54.18% | -107.118M 0.48% | -181.136M -69.10% | -231.072M -27.57% | -268.129M -16.04% | -292.712M -9.17% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -110.03M -54.25% | -112.867M -2.58% | -187.841M -66.43% | -229.441M -22.15% | -258.067M -12.48% | -295.639M -14.56% | -376.07M -27.21% | -358.726M 4.61% | -260.317M 27.43% | -82.351M 68.37% | 145.54M 276.73% | |
| Operating Margin | -3,515.34% | -544.65% | -507,678.38% | -5,306.22% | -8,059.54% | -7,381.75% | -1,885.91% | -330.17% | -98.48% | -16.15% | 18.14% | |
| EPS YoY % growth | -3.32 -29.69% | -2.64 20.48% | -2.98 -12.88% | -3.63 -21.75% | -3.92 -7.96% | -4.02 -2.57% | -4.31 -7.32% | -3.89 9.78% | -2.62 32.52% | -0.53 79.92% | 2.04 487.71% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.89 -41.79% | -0.97 -22.15% | -0.90 0.39% | -1.03 -19.20% |
| Revenue Q2Q % growth | 381.623K 7,532.46% | 380.899K 12,596.62% | 1.867M 186,600.00% | 14.28K 2.00% |
| EBITDA Q2Q % growth | -59.089M -47.39% | -62.75M -35.79% | -68.095M -37.81% | N/A |
| EBIT Q2Q % growth | -57.081M -34.45% | -61.092M -19.48% | -62.156M -10.76% | -70.861M -32.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.86 -30.30% | -0.88 | 0.02 | 2.21% |
| Q4 2024 Q2Q % growth | -0.90 -20.00% | -0.83 | -0.07 | -7.88% |
| Q3 2024 Q2Q % growth | -0.79 -229.17% | -0.72 | -0.07 | -10.47% |
| Q2 2024 Q2Q % growth | -0.63 18.18% | -0.72 | 0.09 | 12.21% |
| Q1 2024 Q2Q % growth | -0.66 25.00% | -0.76 | 0.10 | 13.06% |
| Q4 2023 Q2Q % growth | -0.75 10.71% | -0.76 | 0.01 | 0.80% |
| Q3 2023 Q2Q % growth | -0.24 69.62% | -0.61 | 0.37 | 60.37% |
| Q2 2023 Q2Q % growth | -0.77 11.49% | -0.82 | 0.05 | 6.57% |
| Q1 2023 Q2Q % growth | -0.88 -7.32% | -0.91 | 0.03 | 3.50% |
| Q4 2022 Q2Q % growth | -0.84 1.18% | -0.80 | -0.04 | -4.77% |
| Q3 2022 Q2Q % growth | -0.79 3.66% | -0.93 | 0.14 | 15.12% |
| Q2 2022 Q2Q % growth | -0.87 -210.71% | -0.87 | 0.00 | -0.35% |
| Q1 2022 Q2Q % growth | -0.82 -34.43% | -0.83 | 0.01 | 0.75% |
| Q4 2021 Q2Q % growth | -0.85 63.98% | -0.88 | 0.03 | 3.10% |
| Q3 2021 Q2Q % growth | -0.82 | -0.82 | 0.00 | 0.13% |
| Q2 2021 Q2Q % growth | -0.28 | -0.69 | 0.41 | 59.63% |
| Q1 2021 Q2Q % growth | -0.61 | -1.12 | 0.51 | 45.63% |
| Q4 2020 Q2Q % growth | -2.36 | -0.67 | -1.69 | -250.56% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 14K -50.00% | 390.221K | -376.221K | -96.41% |
| Q4 2024 Q2Q % growth | 1K -100.00% | 1.747M | -1.746M | -99.94% |
| Q3 2024 Q2Q % growth | 3K -99.99% | 569.456K | -566.456K | -99.47% |
| Q2 2024 Q2Q % growth | 5K -97.91% | 1.337M | -1.332M | -99.63% |
| Q1 2024 Q2Q % growth | 28K -90.60% | 800.7K | -772.7K | -96.50% |
| Q4 2023 Q2Q % growth | 20.723M 1,557.84% | 2.104M | 18.619M | 884.93% |
| Q3 2023 Q2Q % growth | 20.204M 3,940.80% | 8.19M | 12.014M | 146.69% |
| Q2 2023 Q2Q % growth | 239K 49.38% | 865.297K | -626.297K | -72.38% |
| Q1 2023 Q2Q % growth | 298K -75.57% | 1.049M | -751K | -71.59% |
| Q4 2022 Q2Q % growth | 1.25M 1,288.89% | 3.066M | -1.816M | -59.23% |
| Q3 2022 Q2Q % growth | 500K -63.50% | 893.775K | -393.775K | -44.06% |
| Q2 2022 Q2Q % growth | 160K -98.90% | 873.12K | -713.12K | -81.67% |
| Q1 2022 Q2Q % growth | 1.22M -39.00% | 775.2K | 444.8K | 57.38% |
| Q4 2021 Q2Q % growth | 90K 109.18% | 918K | -828K | -90.20% |
| Q3 2021 Q2Q % growth | 1.37M -90.61% | 178.5K | 1.192M | 667.51% |
| Q2 2021 Q2Q % growth | 14.58M | 601.8K | 13.978M | 2,322.73% |
| Q4 2020 Q2Q % growth | -980K -148.28% | % | ||
| Q3 2020 Q2Q % growth | 14.589M 2,601.67% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.13% | 1.23% | 0.08% | 0.36% |
| Revenue | 0% | -1.36% | -11.12% | -12.59% |